Lexeo Therapeutics

Lexeo Therapeutics is a clinical-stage genetic medicines company developing gene therapies for cardiovascular and neurological diseases, with a focus on Friedreich's ataxia cardiomyopathy and APOE4-associated Alzheimer's disease.